Until now, Lumigan (bimatoprost ophthalmic solution) 0.03% was used as a second-line treatment for glaucoma. Now the Allergan once-daily prescription eyedrop has been approved for first-line treatment of elevated intraocular pressure associated with open-angle glaucoma or ocular hypertension.
Eyedrop grows from second- to first-line Rx for glaucoma
Until now, Lumigan (bimatoprost ophthalmic solution) 0.03% was used as a second-line treatment for glaucoma. Now the Allergan once-daily prescription eyedrop has been approved for first-line treatment of elevated intraocular pressure associated with open-angle glaucoma or ocular hypertension.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
National Support for Medication Abortion Access Increased Since Dobbs Decision
January 16th 2025Support for and personal interest in expanded access to advance provision and over-the-counter medication abortion has increased significantly since the constitutional right to abortion was overturned by the Supreme Court.